Conflict of interest declaration: Paul Garner

Roles in: Infectious Diseases Group, HIV/AIDS Group

1. In the past three years have you accepted the following from an organisation that may gain or lose financially from the publication of reviews by your review group in the Cochrane Database of Systematic Reviews (CDSR)?

a) Reimbursement for attending a conference or symposium (including travel, accommodation and/or hospitality)?
No

b) Fees for speaking?
No

c) Fees for organising education?
No

d) Funds for research?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty payments?
No

2. In the past three years have you or your spouse/partner been employed by an organization that may in any way gain or lose financially from the publication of reviews by your review group in the CDSR?
No

3. Do you own stocks or shares in companies that may gain or lose financially from the publication of reviews by your review group in the CDSR?
No

4. Do you hold any patents for products that that may lead you to gain or lose financially from the publication of reviews by your review group in the CDSR?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - PG is director of the Research and Evidence for Development Initiative (READ-It, project number 300342-104) funded by UK aid from the UK government. Part of his salary is paid for from this grant, and much of his academic standing relates to outputs from this grant and from evidence synthesis. READ-It aims to to increase the number of evidence-informed decisions by intermediary organisations that benefit the poor in low and middle income countries (LMICs). DFID key performance indicators for READ-It include Cochrane Review production. PG is also the co-ordinator of a World Health Organization Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases (UNK234; apps.who.int/whocc); one of the Centre's aims is to prepare reliable systematic reviews to inform WHO policy. He is also a member of the Cochrane Editorial Board.